DES Biologics Consulting LLC has been retained by several clients in the biotech/pharma and financial investment communities for the following project areas:
- Evaluate novel biologics development programs for virtual and small companies
- Carry out due diligence on biologics for potential acquisition/licensing
- Develop technical transfer strategy of new biologics to potential third party manufacturers of drug substance and drug product
- Review CMC Regulatory documents e.g., INDs/CTAs/BLAs/MAAs
- Conduct webinars and individual consultation on development of biosimilars and current trends
- Perform organizational reviews for the pharmaceutical development and manufacturing groups of clients to help them develop their long-term business and technical strategies
- Provide expert consultation to major financial investment firms to advise clients on new directions in specific biopharmaceutical product development.
- Serve as subject matter expert for patent litigation and other legal matters concerning biologics development and manufacturing.